Form 4: Globus Medical Director Dan Lemaitre Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Director Dan Lemaitre exercised stock options and sold shares of Globus Medical Inc. on May 10, 2024.
Summary
- On May 10, 2024, Dan Lemaitre, a director of Globus Medical Inc., executed multiple transactions involving Class A Common Stock.
- Lemaitre exercised options to acquire 17,500 shares at prices of $43.77, $43.58, and $53.27.
- Following the exercise of these options, Lemaitre sold 63,300 shares at a weighted average price of $64.6133.
- The sale price ranged from $63.80 to $64.68.
- After these transactions, Lemaitre no longer directly owns any Class A Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard SEC filing detailing insider transactions. It doesn't inherently suggest positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a broader trend within the medical device industry.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 01/22/2018 | Date stock options were granted that were exercised on 05/10/2024 at a price of $43.77. |
| 01/22/2019 | Date stock options were granted that were exercised on 05/10/2024 at a price of $43.58. |
| 01/22/2020 | Date stock options were granted that were exercised on 05/10/2024 at a price of $53.27. |
| 01/22/2028 | Expiration date of stock options exercised on 05/10/2024 at a price of $43.77. |
| 01/22/2029 | Expiration date of stock options exercised on 05/10/2024 at a price of $43.58. |
| 01/22/2030 | Expiration date of stock options exercised on 05/10/2024 at a price of $53.27. |
| 05/10/2024 | Date of stock option exercises and share sales by Dan Lemaitre. |
| 05/14/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.